TIRZEPATIDE (10 MG/VIAL – 1 VIAL) – Hilma Biocare
Tirzepatide is a dual agonist of GIP and GLP-1 receptors, designed to stimulate insulin release.
- The description claims that Tirzepatide improves cellular uptake and metabolic stability.
AI Readiness
Good foundation, but some important product data is still missing.
70%